129 related articles for article (PubMed ID: 15214881)
21. Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.
Shigemura K; Shirakawa T; Okada H; Tanaka K; Udaka T; Kamidono S; Arakawa S; Gotoh A
J Microbiol Methods; 2004 Dec; 59(3):415-21. PubMed ID: 15488283
[TBL] [Abstract][Full Text] [Related]
22. Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.
Pinho MD; Melo-Cristino J; Ramirez M;
Antimicrob Agents Chemother; 2010 May; 54(5):1769-77. PubMed ID: 20145082
[TBL] [Abstract][Full Text] [Related]
23. An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae.
Alonso R; Galimand M; Courvalin P
J Antimicrob Chemother; 2004 Apr; 53(4):682-3. PubMed ID: 15014061
[No Abstract] [Full Text] [Related]
24. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).
Davies TA; Yee YC; Goldschmidt R; Bush K; Sahm DF; Evangelista A
J Antimicrob Chemother; 2006 Mar; 57(3):437-42. PubMed ID: 16431861
[TBL] [Abstract][Full Text] [Related]
25. Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing technology.
Hopkins KL; Arnold C; Threlfall EJ
J Microbiol Methods; 2007 Jan; 68(1):163-71. PubMed ID: 16934351
[TBL] [Abstract][Full Text] [Related]
26. In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.
Schafer J; Hovde LB; Simonson D; Rotschafer JC
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):155-61. PubMed ID: 17910998
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of fluoroquinolone-nonsusceptible Streptococcus pyogenes emm12 in Taiwan.
Lin JN; Chang LL; Lai CH; Huang YH; Chen WF; Yang CH; Hsu J; Lin HH; Chen YH
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):187-92. PubMed ID: 26234479
[TBL] [Abstract][Full Text] [Related]
28. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
Alkorta M; Giménez MJ; Vicente D; Aguilar L; Pérez-Trallero E
Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
[TBL] [Abstract][Full Text] [Related]
29. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
Lázaro FG; Rodríguez-Tarazona RE; García-Rodríguez JA; Muñoz-Bellido JL
Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.
Lautenbach E; Fishman NO; Metlay JP; Mao X; Bilker WB; Tolomeo P; Nachamkin I
J Infect Dis; 2006 Jul; 194(1):79-85. PubMed ID: 16741885
[TBL] [Abstract][Full Text] [Related]
31. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
[TBL] [Abstract][Full Text] [Related]
32. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
Kim JY; Kim SH; Jeon SM; Park MS; Rhie HG; Lee BK
Clin Microbiol Infect; 2008 Aug; 14(8):760-5. PubMed ID: 18727800
[TBL] [Abstract][Full Text] [Related]
33. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance.
Yan SS; Fox ML; Holland SM; Stock F; Gill VJ; Fedorko DP
Antimicrob Agents Chemother; 2000 Nov; 44(11):3196-8. PubMed ID: 11036052
[TBL] [Abstract][Full Text] [Related]
34. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan.
Baucheron S; Chaslus-Dancla E; Cloeckaert A; Chiu CH; Butaye P
Antimicrob Agents Chemother; 2005 Feb; 49(2):862-3. PubMed ID: 15673791
[No Abstract] [Full Text] [Related]
35. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates.
Tanaka M; Nakayama H; Notomi T; Irie S; Tsunoda Y; Okadome A; Saika T; Kobayashi I
Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S15-22. PubMed ID: 15364300
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
37. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Rice CL; Doern GV
Clin Infect Dis; 2005 Jan; 40(2):225-35. PubMed ID: 15655739
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of the first fluoroquinolone resistant strains of Streptococcus agalactiae isolated in Brazil.
Barros RR; Kegele FC; Paula GR; Brito MA; Duarte RS
Braz J Infect Dis; 2012; 16(5):476-8. PubMed ID: 22980583
[TBL] [Abstract][Full Text] [Related]
39. Rapid detection of the fluoroquinolone resistance-associated ParC mutation in Neisseria gonorrhoeae using TaqMan probes.
Shigemura K; Shirakawa T; Tanaka K; Arakawa S; Gotoh A; Fujisawa M
Int J Urol; 2006 Mar; 13(3):277-81. PubMed ID: 16643623
[TBL] [Abstract][Full Text] [Related]
40. Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae.
Schurek KN; Adam HJ; Hoban DJ; Zhanel GG
Int J Antimicrob Agents; 2006 Sep; 28(3):266-9. PubMed ID: 16904294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
